• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,155.62 347.14
( 0.45%)
Global Indices
Nasdaq
52,022.73 330.70
(0.64%)
Dow Jones
7,531.82 -43.47
(-0.57%)
Hang Seng
69,975.80 571.30
(0.82%)
Nikkei 225
10,504.45 73.83
(0.71%)
Forex
USD-INR
94.63 -0.29
(-0.31%)
EUR-INR
109.79 -0.04
(-0.03%)
GBP-INR
127.09 -0.16
(-0.13%)
JPY-INR
0.59 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
375.784464
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
33.11
106591.41
EPS(TTM)
Face Value()
Div & Yield %
38.57
1
0.63
 

Bombay Dyeing Q4 PAT jumps 82% YoY to Rs 21 cr
May 09,2026

Revenue from operations increased 10.3% year-on-year to Rs 395.84 crore for the quarter ended 31 March 2026.

Total expenses declined 11.17% year-on-year to Rs 362.43 crore during the quarter. The cost of raw materials fell 26.78% to Rs 204.10 crore, while employee benefit expenses surged 451.07% YoY to Rs 48.99 crore.

On a segmental basis, polyester revenue stood at Rs 367.05 crore (up 11.45% YoY), while the real estate business stood at Rs 18.70 crore (down 8.65% YoY) and revenue from the retail / textile segment stood at Rs 6.84 crore (down 25.65% YoY) during the period under review.

On a full-year basis, the company’s consolidated net profit tanked 94.5% to Rs 26.92 crore on a 9% decline in net sales to Rs 1,460.33 crore in FY26 over FY25.

Bombay Dyeing & Manufacturing Company is currently engaged in the business of real estate development, polyester staple fiber, and retail (textiles).

The scrip shed 0.26% to end at Rs 135.60 on Friday, 8 May 2026.